AAAAAA
Results:
1-7
|
Results: 7
Authors:
Mancini, FP
Lanni, A
Sabatino, L
Moreno, M
Giannino, A
Contaldo, F
Colantuoni, V
Goglia, F
Citation: Fp. Mancini et al., Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats, FEBS LETTER, 491(1-2), 2001, pp. 154-158
Authors:
Vaccaro, O
Perna, AF
Mancini, FP
Iovine, C
Cuomo, V
Sacco, M
Tufano, A
Rivellese, AA
Ingrosso, D
Riccardi, G
Citation: O. Vaccaro et al., Plasma homocysteine and microvascular complications in type 1 diabetes, NUTR MET CA, 10(6), 2000, pp. 297-304
Authors:
Vaccaro, O
Mancini, FP
Ruffa, G
Sabatino, L
Colantuoni, V
Riccardi, G
Citation: O. Vaccaro et al., Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) and severe obesity: a case-control study, INT J OBES, 24(9), 2000, pp. 1195-1199
Authors:
Vaccaro, O
Perna, AF
Mancini, FP
Cuomo, V
Sacco, M
Tufano, A
Rivellese, AA
Ingrosso, D
Riccardi, G
Citation: O. Vaccaro et al., Plasma homocysteine and its determinants in diabetic retinopathy, DIABET CARE, 23(7), 2000, pp. 1026-1027
Authors:
Coppola, A
Davi, G
De Stefano, V
Mancini, FP
Cerbone, AM
Di Minno, G
Citation: A. Coppola et al., Homocysteine, coagulation, platelet function, and thrombosis, SEM THROMB, 26(3), 2000, pp. 243-254
Authors:
Mancini, FP
Vaccaro, O
Sabatino, L
Tufano, A
Rivellese, AA
Riccardi, G
Colantuoni, V
Citation: Fp. Mancini et al., Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma 2 is not associated with type 2 diabetes, DIABETES, 48(7), 1999, pp. 1466-1468
Authors:
Celentano, A
Mancini, FP
Crivaro, M
Palmieri, V
Ferrara, LA
De Stefano, V
Di Minno, G
de Simone, G
Citation: A. Celentano et al., Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension, AM J CARD, 83(8), 1999, pp. 1196-1200
Risultati:
1-7
|